Vivo Capital Closes $1.43 Billion Fund IX
10.31.19
This is only gets display when printing
Simpson Thacher represented Vivo Capital in connection with raising $1.43 billion for Vivo Capital Fund IX, L.P. (“Vivo IX”). Vivo IX, which received committed capital from a broad group of existing and new global institutional investors, is focused on making investments in public and private healthcare and life science companies in the U.S. and China.
The Simpson Thacher team included Michael Nooney, Robert Guo, Jay Higdon, Lu Wang and Brittani Frink (Private Funds); Sarah Katz (Tax); and Jeanne Annarumma (ECEB).